We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PW
4601
Power REIT
PW
$2.94M
$10K ﹤0.01%
15
REPX icon
4602
Riley Exploration Permian
REPX
$801M
$10K ﹤0.01%
529
+101
+24% +$2.24K
RWX icon
4603
State Street SPDR Dow Jones International Real Estate ETF
RWX
$267M
$10K ﹤0.01%
286
+282
+7,050% +$10.2K
SB icon
4604
Safe Bulkers
SB
$790M
$10K ﹤0.01%
2,619
-1,374
-34% -$5.6K
SIF icon
4605
SIFCO Industries
SIF
$126M
$10K ﹤0.01%
1,495
+1,057
+241% +$8.23K
SMBC icon
4606
Southern Missouri Bancorp
SMBC
$844M
$10K ﹤0.01%
198
+46
+30% +$2.4K
SMFG icon
4607
Sumitomo Mitsui Financial
SMFG
$167B
$10K ﹤0.01%
1,385
-631
-31% -$4.27K
SOHU
4608
Sohu.com
SOHU
$377M
$10K ﹤0.01%
622
+522
+522% +$9.85K
TDW icon
4609
Tidewater
TDW
$4.71B
$10K ﹤0.01%
927
-7,095
-88% -$83.4K
TISI icon
4610
Team
TISI
$101M
$10K ﹤0.01%
952
-1,794
-65% -$35.8K
TNXP icon
4611
Tonix Pharmaceuticals
TNXP
$213M
0
UBX
4612
DELISTED
Unity Biotechnology
UBX
$10K ﹤0.01%
703
-924
-57% -$20.2K
UUU icon
4613
Universal Safety Products Inc
UUU
$10.6M
$10K ﹤0.01%
+3,051
New +$13.5K
VALU icon
4614
Value Line
VALU
$343M
$10K ﹤0.01%
203
-210
-51% -$8.3K
VCSH icon
4615
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$10K ﹤0.01%
122
-1,816
-94% -$148K
VEA icon
4616
Vanguard FTSE Developed Markets ETF
VEA
$239B
$10K ﹤0.01%
+197
New +$10.1K
VMBS icon
4617
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.6B
$10K ﹤0.01%
188
+94
+100% +$4.98K
VUG icon
4618
Vanguard Morningstar Growth ETF
VUG
$230B
$10K ﹤0.01%
192
-75,546
-100% -$3.94M
WBX
4619
Wallbox
WBX
$74.2M
$10K ﹤0.01%
+30
New +$8.24K
WPP icon
4620
WPP
WPP
$5.78B
$10K ﹤0.01%
136
-356
-72% -$25.4K
WTBA icon
4621
West Bancorporation
WTBA
$505M
$10K ﹤0.01%
312
-383
-55% -$12.1K
XPRO icon
4622
Expro Ltd
XPRO
$2.11B
$10K ﹤0.01%
666
-9,526
-93% -$156K
ZVIA icon
4623
Zevia
ZVIA
$103M
$10K ﹤0.01%
1,455
+134
+10% +$1.31K
BTX
4624
BlackRock Technology and Private Equity Term Trust
BTX
$1.06B
$10K ﹤0.01%
+689
New +$11.4K
CLYM
4625
Climb Bio
CLYM
$953M
$10K ﹤0.01%
1,001
+510
+104% +$7.6K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.